Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.57
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
6.56
-0.01 (-0.16%)
After-hours: May 22, 2026, 7:59 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Teladoc Health stock has a consensus rating of "Hold" and an average price target of $7.19. The average 1-year stock price forecast is 9.44% higher than the current stock price, while the lowest is $5.00 (-23.90%) and the highest is $10 (+52.21%).
Price Target: $7.19 (+9.44%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Teladoc Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Hold | 10 | 10 | 12 | 13 | 13 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 18 | 18 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | +6.54% | May 5, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | -8.68% | Apr 8, 2026 |
| Barclays | Barclays | Hold Maintains $8.5 → $7 | Hold | Maintains | $8.5 → $7 | +6.54% | Mar 26, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +6.54% | Mar 13, 2026 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $11 | Hold → Strong Buy | Upgrades | $11 | +67.43% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
2.56B
from 2.53B
Increased by 1.07%
Revenue Next Year
2.60B
from 2.56B
Increased by 1.49%
EPS This Year
-0.92
from -1.14
EPS Next Year
-0.70
from -0.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.7B | 2.7B | ||||
| Avg | 2.6B | 2.6B | ||||
| Low | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 5.1% | 6.8% | ||||
| Avg | 1.1% | 1.5% | ||||
| Low | -3.8% | -6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.75 | -0.44 | |||
| Avg | -0.92 | -0.70 | |||
| Low | -1.04 | -1.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.